SHMLF (SHL Telemedicine) YoY EPS Growth: 54.53% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHMLF SHL Telemedicine Ltd SHMLF
56 GF Score
Price $4.84
GF Value $11.86
! 5 Warning Signs
View Full Analysis

What is SHL Telemedicine YoY EPS Growth?

SHL Telemedicine SHMLF 56 YoY EPS Growth is 54.53% as of Dec. 2025. GuruFocus rates SHMLF with a GF Score™ of 56/100 and a GF Value™ of $11.86. The stock has 5 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. SHL Telemedicine's YoY EPS Growth for the quarter that ended in Dec. 2025 was 54.53%.

SHL Telemedicine's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was $-0.57.

SHL Telemedicine YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for SHL Telemedicine's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SHL Telemedicine YoY EPS Growth Chart

SHL Telemedicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,335.29 50.91 -10.00 -368.01 48.20

SHL Telemedicine Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,475.00 4.35 -464.13 -12.88 54.53
SHMLF
56GF Score
SHL Telemedicine Ltd SHMLF
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SHL Telemedicine YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

SHL Telemedicine's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(-0.72--1.39)/ | -1.39 |
=48.20 %

SHL Telemedicine's YoY EPS Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EPS Growth (Q: Dec. 2025 )
=(Earnings per Share (Diluted) (Q: Dec. 2025 )-Earnings per Share (Diluted) (Q: Dec. 2024 )) / | Earnings per Share (Diluted) (Q: Dec. 2024 )) |
=(-0.572--1.258)/ | -1.258 |
=54.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 54.53% mean?
SHL Telemedicine (SHMLF) has a YoY EPS Growth of 54.53% as of Dec. 2025. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for SHL Telemedicine and its competitors.
Is SHL Telemedicine's YoY EPS Growth too high?
SHL Telemedicine's current YoY EPS Growth is 54.53%. Overall, SHL Telemedicine has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does SHL Telemedicine's YoY EPS Growth compare to VEEV and BTSG?
SHL Telemedicine's YoY EPS Growth of 54.53% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Healthcare Providers & Services company?
A good YoY EPS Growth depends on the Healthcare Providers & Services industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for SHL Telemedicine and its competitors. SHL Telemedicine's current YoY EPS Growth is 54.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SHL Telemedicine stock overvalued right now?
SHL Telemedicine (SHMLF) has a current YoY EPS Growth of 54.53%. The stock's GF Value™ is $11.86, compared to a current price of $4.84 — trading 59.2% below its estimated fair value. The current YoY EPS Growth is 54.53%. SHL Telemedicine's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For SHL Telemedicine (SHMLF), the current YoY EPS Growth is 54.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SHL Telemedicine (SHMLF) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of $4.84 is trading 59.2% below its estimated GF Value™ of $11.86.

Key valuation signals for SHMLF:

  • YoY EPS Growth: 54.53%
  • GF Value™: $11.86 vs. price of $4.84 (59.2% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the SHMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SHL Telemedicine Business Description

Other Exchanges 0QMX:UKSHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
56GF Score

Get the complete analysis for SHMLF

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.84
Price
$11.86
GF Value